Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Stanford University
Case Comprehensive Cancer Center
Weprom
Institut Bergonié
Wake Forest University Health Sciences
University of Washington
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center